Latest News & Features
Biotechnology
“Customer suit exception” is rejected by district judge | Suit between Chr. Hansen and Glycosyn is ongoing. 14 March 2023
Biotechnology
The Pharmaceutical Accountability Foundation has accused the pharma giant of excessively pricing its blockbuster drug, and believes it could influence the regulation of pricing and patent policy for global medicines in the process. 9 March 2023
Big Pharma
Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand. 9 March 2023
Big Pharma
The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute. 7 March 2023
Big Pharma
The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri. 7 March 2023
Big Pharma
Health-related patents fell during 2022 against a backdrop of record global patents filed | Biotechnology was fastest growing field among Patent Cooperation Treaty applications | COVID-19 pandemic caused large falls in goods classes such as pharmaceuticals. 2 March 2023
Biotechnology
Boehringer Ingelheim challenged university patent | Board must provide more details on ruling. 2 March 2023
article
Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets. 28 February 2023
article
The move marks the firm’s second western merger this year | Joining firm has a strong presence in Denver and Asia markets. 28 February 2023
Big Pharma
Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel. 28 February 2023